AXGN STOCK ANALYSIS

Axogen Inc — price, returns and risk statistics

AXGNAxogen Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Last Close

45.89 $

Jul 2, 26

Market Cap

2.4 B $

Q1 2026 (TTM)

52-Week Range

Total Return

%+314.9

Trailing 1-year performance

Volatility

%54.3

Price fluctuation measure

Sharpe Ratio

2.16

Risk/Return ratio

Sortino Ratio

2.61

Downside risk/return

Distance to Peak

%-0.6

Difference from 52-week peak

Maximum Drawdown

-%19.3

Deepest 1-year decline

Seasonality Chart

Year 2023

Year 2024

Year 2025

Current Period 2026

3/3 positive months

Periodic Returns

+16.3%

+33.2%

+40.2%

YTD

+40.2%

+314.9%

+418.5%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly Avg Positive/Negative Close

Positive Count

Negative Count

Average Positive %

Average Negative %

Frequently Asked Questions

What is the current Axogen Inc (AXGN) stock price?

AXGN last closed at 45.89 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of Axogen Inc?

Axogen Inc (AXGN) has a market capitalization of approximately 2.4 B $ as of the latest reported period.

Who are the main competitors of AXGN?

Key peers of Axogen Inc include 4DMEDICAL Ltd, Cochlear Ltd, Koninklijke Philips NV, Smith & Nephew PLC, Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi. A detailed metric comparison is available on the Peers tab.

Go deeper on AXGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.